ENTITY
Celltrion

Celltrion (068270 KP)

28
Analysis
Health Care • South Korea
Celltrion, Inc. produces and sells biosimilar products, as well as consignment processing services for other businesses.
more
bearish•Celltrion Inc
•13 Dec 2018 10:06

Celltrion / Celltrion Healthcare Pair Trade: Ratio Should Move in Favor of Healthcare

I initiated a pair trade (short Celltrion / long Healthcare) on Oct 22. Yield peaked at 16.66% on Nov 22. It now stays at 8.75%. The ongoing FSS...

Logo
757 Views
Share
bearish•Celltrion Inc
•28 Nov 2018 00:29

Biosimilar Battlefield Update: It's Getting Uglier

A confluence of negative news is causing sharp declines (or trading suspensions) in the share prices of Samsung Biologics Co., (207940...

Share
bearish•Bombardier Inc
•16 Nov 2018 11:07

Reality Overwhelms Creative Accounting

Bombardier Inc (BBD/B CN) has recently fallen 38%, ThyssenKrupp AG (TKA GR) 18%  and Celltrion Inc (068270 KS) 30%.  In each case, the market was...

bullish•Samsung C&T
•15 Nov 2018 08:12

Samsung BioLogics Trade Suspension: Short Celltrion/Long Samsung C&T

The FSC said it had found intentionality behind BioLogics’ breach of accounting rules. Hence, the FSC pressed criminal charges against BioLogics...

Logo
664 Views
Share
bearish•Babytree
•27 Oct 2018 14:03

ECM Weekly (27 October 2018) - Wanka, CanSino, PEXA, Bitmain, Celltrion, Coronado

Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...

Share
x